Celularity Book Value Per Share vs Ev To Sales Analysis

CELUW Stock

USD 0.04 0 2.44%

Celularity financial indicator trend analysis is way more than just evaluating Celularity prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Celularity is a good investment. Please check the relationship between Celularity Book Value Per Share and its Ev To Sales accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Celularity. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment.

For more information on how to buy Celularity Stock please use our How to Invest in Celularity guide.

Book Value Per Share vs Ev To Sales

Book Value Per Share vs Ev To Sales Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Celularity Book Value Per Share account and Ev To Sales. At this time, the significance of the direction appears to have significant contrarian relationship.

The correlation between Celularity's Book Value Per Share and Ev To Sales is -0.27. Overlapping area represents the amount of variation of Book Value Per Share that can explain the historical movement of Ev To Sales in the same time period over historical financial statements of Celularity, assuming nothing else is changed. The correlation between historical values of Celularity's Book Value Per Share and Ev To Sales is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Book Value Per Share of Celularity are associated (or correlated) with its Ev To Sales. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Ev To Sales has no effect on the direction of Book Value Per Share i.e., Celularity's Book Value Per Share and Ev To Sales go up and down completely randomly.

Correlation Coefficient

-0.27

Relationship Direction	Negative
Relationship Strength	Insignificant

View All Relationships

Book Value Per Share

The ratio of equity available to common shareholders divided by the number of outstanding shares. This measure represents the value per share of a company according to its financial statements.

Ev To Sales

The Enterprise Value to Sales ratio, a valuation metric used to compare the value of a company, including debt and excluding cash, to its sales revenue.

Most indicators from Celularity's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Celularity current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Celularity. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment.

For more information on how to buy Celularity Stock please use our How to Invest in Celularity guide.Tax Provision is likely to climb to about 12.1 K in 2025, whereas Selling General Administrative is likely to drop slightly above 49.4 M in 2025.

	2022	2023	2024	2025 (projected)
Total Revenue	18.0M	22.8M	26.2M	21.7M
Depreciation And Amortization	9.4M	9.3M	10.7M	16.3M

Total Revenue Depreciation And Amortization

Celularity fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Cash And Short Term Investments	Net Receivables	Good Will	Common Stock Shares Outstanding	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Intangible Assets	Common Stock	Net Tangible Assets	Warrants
Total Assets		0.68	0.93	0.57	-0.06	0.91	0.31	-0.73	0.14	0.74	-0.6	-0.16	0.16	0.74	0.41	-0.25	-0.94	0.6	0.21	0.7	0.71	0.86	-0.76	0.24	-0.76	-0.76
Short Long Term Debt Total	0.68		0.79	0.97	0.18	0.9	0.77	-0.9	0.68	0.23	-0.89	0.02	0.56	0.23	0.89	-0.75	-0.72	0.63	0.0	0.93	0.32	0.6	-0.93	0.07	-0.89	-0.89
Other Current Liab	0.93	0.79		0.75	-0.2	0.93	0.4	-0.84	0.39	0.72	-0.65	0.13	0.38	0.72	0.64	-0.4	-0.82	0.63	0.36	0.77	0.75	0.93	-0.84	-0.04	-0.89	-0.89
Total Current Liabilities	0.57	0.97	0.75		0.09	0.82	0.75	-0.92	0.8	0.2	-0.84	0.26	0.6	0.2	0.95	-0.79	-0.57	0.65	0.06	0.91	0.3	0.59	-0.91	-0.18	-0.91	-0.91
Total Stockholder Equity	-0.06	0.18	-0.2	0.09		0.01	0.52	0.05	-0.01	-0.59	-0.14	-0.4	0.09	-0.59	-0.05	-0.11	-0.08	0.21	-0.54	0.24	-0.73	-0.52	0.0	0.41	0.1	0.1
Property Plant And Equipment Net	0.91	0.9	0.93	0.82	0.01		0.56	-0.9	0.49	0.56	-0.85	-0.08	0.43	0.56	0.72	-0.58	-0.93	0.71	0.03	0.89	0.59	0.81	-0.94	0.18	-0.91	-0.91
Net Debt	0.31	0.77	0.4	0.75	0.52	0.56		-0.63	0.52	-0.34	-0.8	-0.07	0.71	-0.34	0.7	-0.8	-0.43	0.38	-0.17	0.79	-0.22	0.12	-0.69	0.13	-0.62	-0.61
Retained Earnings	-0.73	-0.9	-0.84	-0.92	0.05	-0.9	-0.63		-0.74	-0.42	0.86	-0.3	-0.52	-0.42	-0.87	0.77	0.7	-0.78	-0.02	-0.95	-0.48	-0.76	0.98	0.2	0.99	0.99
Accounts Payable	0.14	0.68	0.39	0.8	-0.01	0.49	0.52	-0.74		0.01	-0.65	0.53	0.66	0.02	0.9	-0.81	-0.19	0.67	-0.25	0.7	0.07	0.32	-0.69	-0.46	-0.72	-0.72
Cash	0.74	0.23	0.72	0.2	-0.59	0.56	-0.34	-0.42	0.01		-0.12	0.15	-0.15	1.0	0.12	0.15	-0.56	0.4	0.42	0.23	0.94	0.87	-0.38	-0.1	-0.47	-0.47
Non Current Assets Total	-0.6	-0.89	-0.65	-0.84	-0.14	-0.85	-0.8	0.86	-0.65	-0.12		0.1	-0.67	-0.12	-0.84	0.9	0.75	-0.57	0.25	-0.9	-0.25	-0.52	0.94	-0.19	0.85	0.84
Non Currrent Assets Other	-0.16	0.02	0.13	0.26	-0.4	-0.08	-0.07	-0.3	0.53	0.15	0.1		0.15	0.15	0.32	-0.19	0.38	0.29	0.33	0.14	0.14	0.24	-0.11	-0.99	-0.3	-0.3
Other Assets	0.16	0.56	0.38	0.6	0.09	0.43	0.71	-0.52	0.66	-0.15	-0.67	0.15		-0.15	0.73	-0.75	-0.28	0.4	-0.17	0.6	-0.03	0.2	-0.58	-0.09	-0.6	-0.59
Cash And Short Term Investments	0.74	0.23	0.72	0.2	-0.59	0.56	-0.34	-0.42	0.02	1.0	-0.12	0.15	-0.15		0.12	0.15	-0.56	0.4	0.42	0.23	0.94	0.87	-0.38	-0.1	-0.47	-0.47
Net Receivables	0.41	0.89	0.64	0.95	-0.05	0.72	0.7	-0.87	0.9	0.12	-0.84	0.32	0.73	0.12		-0.88	-0.45	0.57	-0.03	0.83	0.27	0.53	-0.87	-0.24	-0.86	-0.86
Good Will	-0.25	-0.75	-0.4	-0.79	-0.11	-0.58	-0.8	0.77	-0.81	0.15	0.9	-0.19	-0.75	0.15	-0.88		0.39	-0.49	0.3	-0.8	-0.01	-0.3	0.81	0.12	0.74	0.74
Common Stock Shares Outstanding	-0.94	-0.72	-0.82	-0.57	-0.08	-0.93	-0.43	0.7	-0.19	-0.56	0.75	0.38	-0.28	-0.56	-0.45	0.39		-0.59	0.08	-0.73	-0.56	-0.71	0.79	-0.47	0.72	0.72
Inventory	0.6	0.63	0.63	0.65	0.21	0.71	0.38	-0.78	0.67	0.4	-0.57	0.29	0.4	0.4	0.57	-0.49	-0.59		-0.32	0.8	0.24	0.52	-0.72	-0.2	-0.76	-0.76
Other Current Assets	0.21	0.0	0.36	0.06	-0.54	0.03	-0.17	-0.02	-0.25	0.42	0.25	0.33	-0.17	0.42	-0.03	0.3	0.08	-0.32		-0.13	0.53	0.44	0.05	-0.35	-0.09	-0.09
Other Stockholder Equity	0.7	0.93	0.77	0.91	0.24	0.89	0.79	-0.95	0.7	0.23	-0.9	0.14	0.6	0.23	0.83	-0.8	-0.73	0.8	-0.13		0.26	0.6	-0.96	-0.04	-0.94	-0.94
Total Liab	0.71	0.32	0.75	0.3	-0.73	0.59	-0.22	-0.48	0.07	0.94	-0.25	0.14	-0.03	0.94	0.27	-0.01	-0.56	0.24	0.53	0.26		0.92	-0.46	-0.09	-0.53	-0.53
Total Current Assets	0.86	0.6	0.93	0.59	-0.52	0.81	0.12	-0.76	0.32	0.87	-0.52	0.24	0.2	0.87	0.53	-0.3	-0.71	0.52	0.44	0.6	0.92		-0.74	-0.16	-0.81	-0.81
Intangible Assets	-0.76	-0.93	-0.84	-0.91	0.0	-0.94	-0.69	0.98	-0.69	-0.38	0.94	-0.11	-0.58	-0.38	-0.87	0.81	0.79	-0.72	0.05	-0.96	-0.46	-0.74		0.01	0.97	0.97
Common Stock	0.24	0.07	-0.04	-0.18	0.41	0.18	0.13	0.2	-0.46	-0.1	-0.19	-0.99	-0.09	-0.1	-0.24	0.12	-0.47	-0.2	-0.35	-0.04	-0.09	-0.16	0.01		0.2	0.2
Net Tangible Assets	-0.76	-0.89	-0.89	-0.91	0.1	-0.91	-0.62	0.99	-0.72	-0.47	0.85	-0.3	-0.6	-0.47	-0.86	0.74	0.72	-0.76	-0.09	-0.94	-0.53	-0.81	0.97	0.2		1.0
Warrants	-0.76	-0.89	-0.89	-0.91	0.1	-0.91	-0.61	0.99	-0.72	-0.47	0.84	-0.3	-0.59	-0.47	-0.86	0.74	0.72	-0.76	-0.09	-0.94	-0.53	-0.81	0.97	0.2	1.0

Click cells to compare fundamentals

Celularity Account Relationship Matchups

Celularity fundamental ratios Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	431.0M	414.1M	401.1M	143.9M	165.5M	286.9M
Short Long Term Debt Total	30.6M	31.1M	65.6M	65.4M	75.2M	40.5M
Other Current Liab	18.3M	11.7M	16.4M	2.4M	11.1M	8.6M
Total Current Liabilities	26.7M	26.2M	62.1M	67.3M	77.4M	39.3M
Total Stockholder Equity	(531.4M)	99.4M	198.9M	41.0M	47.1M	49.5M
Property Plant And Equipment Net	90.1M	90.6M	88.7M	78.8M	90.6M	78.2M
Net Debt	(23.7M)	(6.1M)	51.6M	39.0M	65.2M	68.4M
Retained Earnings	(563.6M)	(663.7M)	(645.5M)	(841.8M)	(757.6M)	(795.5M)
Accounts Payable	5.4M	9.3M	5.8M	14.1M	16.3M	8.5M
Cash	54.3M	37.2M	14.0M	227K	204.3K	194.1K
Non Current Assets Total	358.8M	376.9M	367.6M	124.1M	111.7M	106.1M
Non Currrent Assets Other	20.1M	39.8M	23.3M	26.9M	31.0M	32.5M
Cash And Short Term Investments	54.3M	37.2M	14.0M	227K	261.1K	248.0K
Net Receivables	6.6M	5.2M	7.0M	10.0M	12.1M	7.5M
Common Stock Shares Outstanding	9.2M	6.7M	15.0M	19.4M	17.8M	12.2M
Liabilities And Stockholders Equity	431.0M	414.1M	401.1M	143.9M	165.5M	308.3M
Inventory	3.9M	9.5M	5.3M	5.8M	6.6M	5.8M
Other Current Assets	7.4M	2K	7.3M	329K	1.7M	2.3M
Other Stockholder Equity	32.2M	763.1M	844.4M	882.7M	1.0B	1.1B
Total Liab	962.4M	314.7M	202.2M	102.9M	92.6M	88.0M
Total Current Assets	72.2M	37.2M	33.5M	19.8M	22.8M	28.8M
Accumulated Other Comprehensive Income	(723.7M)	(550.1M)	(414.1M)	9K	10.4K	10.9K
Intangible Assets	125.4M	123.2M	121.0M	11.0M	9.9M	9.4M
Common Stock	1K	12K	15K	19K	17.1K	16.2K
Non Current Liabilities Total	935.7M	288.5M	140.1M	35.6M	32.1M	30.5M
Non Current Liabilities Other	74.6M	232.6M	106.3M	1.9M	2.2M	2.1M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

ZLAB	Zai Lab
ASLE	AerSale Corp
ATS	AT S Austria

Additional Tools for Celularity Stock Analysis

When running Celularity's price analysis, check to measure Celularity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Celularity is operating at the current time. Most of Celularity's value examination focuses on studying past and present price action to predict the probability of Celularity's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Celularity's price. Additionally, you may evaluate how the addition of Celularity to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Celularity Book Value Per Share vs Ev To Sales Analysis

Book Value Per Share vs Ev To Sales

Book Value Per Share vs Ev To Sales Correlation Analysis

Correlation Coefficient

Book Value Per Share

Ev To Sales

Celularity fundamental ratios Correlations

Celularity Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Celularity fundamental ratios Accounts

Also Currently Popular

Additional Tools for Celularity Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Cash
Warrants	+ 1.0	Net Tangible Assets
Net Tangible Assets	+ 0.99	Retained Earnings
Warrants	+ 0.99	Retained Earnings
Intangible Assets	+ 0.98	Retained Earnings
Total Current Liabilities	+ 0.97	Short Long Term Debt Total

Common Stock	- 0.99	Non Currrent Assets Other
Intangible Assets	- 0.96	Other Stockholder Equity
Other Stockholder Equity	- 0.95	Retained Earnings
Warrants	- 0.94	Other Stockholder Equity
Net Tangible Assets	- 0.94	Other Stockholder Equity
Intangible Assets	- 0.94	Property Plant And Equipment Net